Novartis | Driftskostnader

Operating Expenses Endring Dato
AbbVie USD 9.35B 1.76B 2024-03
Alcon AG USD 2.09B 53M 2024-03
Almirall EUR 264.3M 208.3M 2024-03
Amgen USD 6.46B 469M 2024-03
AstraZeneca USD 9.56B 1.23B 2024-03
Bayer EUR 10.67B 1000M 2024-03
Biogen USD 1.72B 306.9M 2024-03
Bristol-Myers Squibb USD 10.35B 728M 2024-03
Eli Lilly USD 6.03B 933.2M 2024-03
Fresenius EUR 5.14B 448M 2024-03
Fresenius Medical Care EUR 4.36B 196.96M 2024-03
Galapagos EUR 95.56M 71.01M 2024-03
Genmab DKK 3.34B 334M 2024-03
Gilead Sciences USD 6.88B 1.37B 2024-03
GlaxoSmithKline GBP 5.87B 1.61B 2024-03
GRIFOLS EUR 1.51B 167.87M 2023-12
Hikma Pharmaceutical USD 1.18B 60M 2023-06
J&J USD 15.11B 1.46B 2024-03
Lonza CHF 2.54B 193M 2023-06
Merck EUR 4.19B 0 2024-03
Merck USD 10.02B 6.55B 2024-03
Novartis USD 8.75B 447M 2024-03
Novartis USD 8.75B 447M 2024-03
Orion EUR 252.5M 31.4M 2024-03
Pfizer USD 10.68B 10.12B 2024-03
Philips EUR 4.96B 77M 2024-03
Recordati EUR 416.04M 30.32M 2024-03
Regeneron Pharmaceuticals USD 2.39B 74.9M 2024-03
Roche Holding CHF 20.02B 5.04B 2023-06
Sanofi EUR 8.89B 600M 2024-03
UCB EUR 2.11B 388M 2023-06



Novartis Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.